12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·16 hours agoNUWE+135.45%QURE+5.29%
CDNA: Q2 2026 revenue rose 52% to $132M, net income hit $111M, boosted by a major asset saleQuartr·17 hours agoCDNA+7.60%
From AI Pivots to Reverse Splits: U.S. Micro-Caps Embrace Aggressive Restructuring in JulyGlobal Report·Jul 19 at 04:13 AMSDEV+4.42%CRDF+5.06%
The 2026 Micro-Catalyst Market: Why Precision Genomics and Premium Tea Are Moving the NeedleGlobal Report·Jul 18 at 04:12 AMSMTK+1.11%VCIG-10.41%
CareDx director Hannah Valantine disposes of common shares worth $1.04 millionPUBT·Jul 17 at 03:23 PMCDNA+7.60%
Biotech Stocks At 52-Week Highs- CDNA, IART, AGL, BVS, ELVNrttnews·Jul 17 at 04:18 AMIART+3.82%BVS+0.46%
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watchrttnews·Jul 16 at 09:58 PMAPLM-0.74%ATAI0.00%
CareDx Upgraded on Strong MolDx Reimbursement Decision as Massaro Lifts Price Target from $28 to $45Tip Ranks·Jul 16 at 12:25 PMCDNA+7.60%
Matt Larew Reiterates Hold on CareDx as Favorable MolDX Coverage Decision Removes Key Reimbursement Overhang but Valuation Now Seen as FairTip Ranks·Jul 16 at 10:25 AMCDNA+7.60%
